Actavia is a game changer in consultancy. All its members are former C-Levels operating in various industries with a key expertise in healthcare, innovation and digital transformation. Based since 8 to 15 years in Asia, they have developed an ecosystem in the region that makes them the perfect partner for your one stop entry point in Asia.
Aesculape is a company organizing clinical studies in Europe, with offices in Belsele, Milan, Seville and Warsaw. The company offers the full range of clinical research services and focuses on oncology, genetic and cellular treatment studies, cardiovascular, metabolic and nervous system diseases.
We develop innovative, wearable, combination-therapy, medical devices.
CicaLux is our first product line to market targeting the OB/GYN, Dermatology, and Aesthetic-General Surgery fields.
ATB Therapeutics has engineered a proprietary technology to manufacture a unique kind of immunotherapeutic designed to combine very high efficacy with unprecedent safety profile.
ATB Therapeutics was funded in 2017 and aims to generate a pipeline of assets for hard-to-treat hematological and solid cancers. The company is now entering preclinical stage.